General
European countries consider mixing COVID-19 vaccines because of AstraZeneca concerns
Several European countries are considering mixing COVID-19 vaccines for citizens who received a first dose of AstraZeneca’s shot, an unprecedented move highlighting the challenge for governments struggling to tame rising infections.
Key points:
- Concerns over the safety of the AstraZeneca vaccine have led to countries pausing their rollout
- Some people who received their first COVID-19 shot, are no longer eligible to receive the second
- There is no evidence that mixing vaccines will be as effective against COVID-19
Vaccination programs have been disrupted after a small number of reports that recipients of the AstraZeneca inoculation suffered extremely rare blood clots, leading some countries worldwide to suspend its use out of caution.
Those…
-
Business15 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
Business18 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
Business19 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI
-
Noosa News9 hours agoSenior constable injured in crash between unmarked police car and stolen vehicle in Pimpama, Queensland